Ad is loading...
ADNRX vs RPMGX
ADNRX vs RPMGX Comparison
Open Charts ADNRX vs RPMGX
American Beacon ARK Transfmt Innov R6
Price$17.05
Change+$0.16 (+0.95%)
VolumeN/A
Net Assets196.84M
T. Rowe Price Mid-Cap Growth
Price$103.80
Change-$0.12 (-0.12%)
VolumeN/A
Net Assets31.16B
ADNRX vs RPMGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VS
ADNRX vs. RPMGX commentary
Jan 23, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADNRX is a Hold and RPMGX is a Hold.
FUNDAMENTALS
Fundamentals
RPMGX has more cash in the bank: 31.2B vs. ADNRX (197M). RPMGX pays higher dividends than ADNRX: RPMGX (0.05) vs ADNRX (0.00). ADNRX was incepted earlier than RPMGX: ADNRX (4 years) vs RPMGX (33 years). ADNRX is a more actively managed with annual turnover of: 33.00 vs. RPMGX (21.70). ADNRX has a lower initial minimum investment than RPMGX: ADNRX (0) vs RPMGX (2500). ADNRX annual gain was more profitable for investors over the last year : 31.15 vs. RPMGX (2.65).
| ADNRX | RPMGX | ADNRX / RPMGX | |
| Total Expense Ratio | N/A | N/A | - |
| Annual Report Gross Expense Ratio | N/A | N/A | - |
| Fund Existence | 4 years | 33 years | - |
| Gain YTD | 9.365 | 4.081 | 229% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 2500 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 197M | 31.2B | 1% |
| Annual Yield % from dividends | 0.00 | 0.05 | - |
| Returns for 1 year | 31.15 | 2.65 | 1,175% |
| Returns for 3 years | -19.23 | 0.95 | -2,034% |
| Returns for 5 years | N/A | 6.76 | - |
| Returns for 10 years | N/A | 38.25 | - |
View a ticker or compare two or three
VS
VS
Ad is loading...